Characterization of platelet glycoproteins and platelet/endothelial cell antibodies in patients with thrombotic thrombocytopenic purpura

British Journal of Haematology

Volumn 107, Issue 3, 1999, Pages 546-555

  Wright, J F ^a,c   Wang, H ^a   Hornstein, A ^a   Hogarth, M ^a   Mody, M ^a   Garvey, M B ^a,c   Blanchette, V ^b,c   Rock, G ^d   Freedman, J ^a,c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

CD36; Endothelial cells; Platelets; Thrombotic thrombocytopenic purpura

Indexed keywords

CD36 ANTIGEN; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB; THROMBOCYTE ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0032755412     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01751.x     Document Type: Article

References (37)

1. Ahn, Y.S., Jy, W., Kolodny, L., Horstman, L.L., Mao, W-W., Valant, P.A. & Duncan, R.C. (1996) Activated platelet aggregates in thrombotic thrombocytopenic purpura: decrease with plasma infusion and normalization in remission. British Journal of Haematology. 95, 408-415.
2. Ansell, J., Beaser, R.S. & Pechet, L. (1978) Thrombotic thrombocytopenic purpura fails to respond to fresh frozen plasma infusion. Annals of Internal Medicine, 89, 647-648.
3. Braine, M.C. & Neame, P.B. (1982) Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. Seminars in Thrombosis and Hemostasis, 8, 186-187.
4. Burns, E.R. & Zucker-Franklin, D. (1982) Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells. Blood, 60, 1030-1037.
5. Cines, D.B. & Schreiber, A.D. (1979) Immune thrombocytopenia: use of a Coombs antiglobulin test to detect IgG and C, on platelets. New England Journal of Medicine, 300, 647-648.
6. Cofrancesco, E., Pogliani, E.M., Savator, M. & Polli, E.E. (1982) Demonstration of immune complexes in thrombotic thrombocytopenic purpura: failure to respond to plasma exchange. Transfusion, 22, 540-541.
7. Consonni, R., Falanga, A. & Barbui, T. (1994) Further characterization of platelet-aggregating cysteine proteinase activity in thrombotic thrombocytopenic purpura. British Journal of Haematology, 87, 321-324.
8. Freedman, J. & Hornstein, A. (1991) Simple method for differentiating between HLA and platelet-specific antibodies by flow cytometry. American Journal of Hematology, 38, 314-320.
9. Garvey, M.B. & Freedman, J. (1983) Complement in thrombotic thrombocytopenic purpura. American Journal of Hematology, 15, 397-398.
10. Greenwalt, D.E., Lipsky, R.H., Ockenhouse, C.F., Ikeda, H., Tandon, N.N. & Jamieson, G.A. (1992) Membrane glycoprotein CD36: a review of its role in adherence, signal transduction and transfusion medicine. Blood. 80, 1105-1115.
11. Hoffman, M., Monroe, D.M. & Roberts, H.R. (1993) Platelet activation in patients with thrombotic thrombocytopenic purpura. American Journal of Hematology, 42, 182-185.
12. Kelton, J.G., Neame, P.B., Walker, I., Turpie, A.G., McBride, J., Han, P., Nicholson, W. & Hirsch J. (1979) Thrombotic thrombocytopenic purpura: mechanism for effectiveness of plasmapheresis. (Abstract). Thrombosis and Haemostasis, 42, 115.
13. Kelton, J.G., Warkentin, T.E., Hayward, C.P.M., Murphy, W.G. & Moore, J.C. (1992) Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles. Blood, 80, 2246-2251.
14. Kühne, T., Hornstein, A., Semple, J.W., Chang, W., Blanchette, V. & Freedman, J. (1995) Flow cytometric evaluation of platelet activation in blood collected in EDTA vs. Diatube-H, a sodium citrate solution supplemented with theophylline, adenosine, and dipyridamole. American Journal of Hematology, 50, 40-45.
15. Laurence, J., Mitra, D., Steiner, M., Staiano-Coico, X. & Jaffe, E. (1996) Plasma from patients with idiopathic and human immunodeficiency virus associated thrombotic thrombocytopenic purpura induces apoptosis in microvascular endothelial cells. Blood, 87, 3245-3254.
16. Leung. D.Y.M., Moake, J.L., Havens, P.L., Kim, M. & Pober, J.S. (1988) Lytic antiendothelial cell antibodies in hemolytic uremic syndrome. Lancet, ii, 183-186.
17. Lian, E.C.Y., Siddiqui, F.A., Jamieson, G.A. & Tandon, N.N. (1991) Platelet agglutinating protein p37 causes platelet activation through its binding to membrane glycoprotein IV. Thrombosis and Haemostasis, 65, 102-106.
18. Lim, V.L., Gumbart, M. & Garovoy, M.R. (1989) A flow cytometric method for the detection of the development of antibody to orthoclone OKT3. Journal of Immunological Methods, 121, 197-201.
19. Meister, R.J., Sacker, R.A. & Phillips, T. (1979) Immune complexes in thrombotic thrombocytopenic purpura. Annals of Internal Medicine, 90, 717.
20. Mitra, D., Jaffe, E.A., Weksler, B., Hajjar, K.A., Sorderland, C. & Laurence, J. (1997) Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells. Blood, 89, 1224-1234.
21. Moake, J.L. & McPherson, P.D. (1989) Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. American Journal of Medicine, 87, 9N-13N.
22. Moore, J.C., Murphy, W.G. & Kelton, J.G. (1990) Calpain proteolysis of von Willebrand factor enhances its binding of platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura. British Journal of Haematology, 74, 457-464.
23. Morrison, J. & McMillan, R. (1977) Elevated platelet-associated IgG in thrombotic thrombocytopenic purpura. Journal of the American Medical Association, 238, 1944-1945.
24. Murphy, W.G., Moore, J.C. & Kelton, J.G. (1987) Calcium-dependent cysteine protease activity in the sera of patients with thrombotic thrombocytopenic purpura. Blood, 70, 1683-1687.
25. Neame, P.B. (1980) Immunologic and other factors in thrombotic thrombocytopenic purpura. Seminars in Thrombosis and Hemostasis, 6, 416-429.
26. Remuzzi, G., Marchesi, D., Mecca, G., Misiani, R., Livio, M., Gaetano, G. & Donati, M.B. (1978) Hemolytic uremic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity? Lancet, ii, 871-872.
27. Rock, G., Kelton, J.G., Shumak, K.H., Buskard, N.A., Sutton, D.C., Benny, W.B., and members of the Canadian Apheresis Group (1998) Laboratory abnormalities in thrombotic thrombocytopenic purpura. British Journal of Haematology, 103, 1031-1036.
28. Rock, G., Tittley, P. & Taylor, J.R. (1988) Abnormal platelet von Willebrand factor interaction in patients with thrombotic thrombocytopenic purpura. American Journal of Hematology, 27, 179-183.
29. Rock, G.A., Shumak, K.H., Buskard, N.A., Blanchette, V.S., Kelton, J.G., Nair, R.C. & Spasoff, R.A. (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. New England Journal of Medicine, 325, 393-397.
30. Schultz, D.R., Arnold, P.I., Jy, W., Valant, P.A., Gruber, J., Ahn, Y.S., Mao, F.W., Mao, W.W. & Horstman, L.L. (1998) Anti-CD36 autoantibodies in thrombotic thrombocytopenic purpura and other thrombotic disorders: identification of an 85 kD form of CD36 as a target antigen. British Journal of Haematology, 103, 849-857.
31. Schwartz, A., Fernandez-Repollet, E., Velilla, M. & Ocasio, B. (1990) Calibration of flow cytometers to directly measure numbers of antibodies binding sites on cells. Cytometry, Suppl. 4, 463B.
32. Semple, J.W., Milev, Y., Cosgrave, D., Mody, M., Hornstein, A., Blanchette, V. & Freedman, J. (1996) Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity. Blood, 87, 4245-4254.
33. Siddiqui, R.A. & Lian, E.C. (1988) Platelet-agglutinating protein p37 from a thrombotic thrombocytopenic purpura plasma forms a complex with human immunoglobulin G. Blood, 71, 299-304.
34. Swerlick, R.A., Lee, K., Wick, T.M. & Lawley, T.J. (1992) Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. Journal of Immunology, 148, 78-83.
35. Tandon, N.N., Jamieson, G.A. & Rock, G. (1991) Identification of antibodies against GPIV (CD36) in the sera of TTP patients. (Abstract). Blood, 78, (Suppl. I), 734.
36. Tandon, N.N., Rock, G. & Jamieson, G.A. (1994) Anti-CD36 antibodies in thrombotic thrombocytopenic purpura. British Journal of Haematology, 88, 816-825.
37. Valant, P.A.. Jy, W., Horstman, L.L., Mao, W-W. & Ahn, Y.S. (1998) Thrombotic thrombocytopenic purpura plasma enhances platelet -leucocyte interaction in vitro. British Journal of Haematology, 100, 24-32.